These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 14580054

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dolasetron decreases postoperative nausea and vomiting after breast surgery.
    Abou Zeid H, Al-Gahamdi A, Abdul-Hadi M.
    Breast J; 2002; 8(4):216-21. PubMed ID: 12100113
    [Abstract] [Full Text] [Related]

  • 3. Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children.
    Sukhani R, Pappas AL, Lurie J, Hotaling AJ, Park A, Fluder E.
    Anesth Analg; 2002 Nov; 95(5):1230-5, table of contents. PubMed ID: 12401599
    [Abstract] [Full Text] [Related]

  • 4. Placebo-controlled comparison of dolasetron and metoclopramide in preventing postoperative nausea and vomiting in patients undergoing hysterectomy.
    Piper SN, Triem JG, Maleck WH, Fent MT, Hüttner I, Boldt J.
    Eur J Anaesthesiol; 2001 Apr; 18(4):251-6. PubMed ID: 11350463
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Prophylaxis of nausea and vomiting after thyroid surgery: comparison of oral and intravenous dolasetron with intravenous droperidol and placebo].
    Danner K, Becker HG, Best B, Madler C.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):425-30. PubMed ID: 11496617
    [Abstract] [Full Text] [Related]

  • 8. Dolasetron for the prevention of postoperative nausea and vomiting following outpatient surgery with general anaesthesia: a randomized, placebo-controlled study. The Dolasetron PONV Prevention Study Group.
    Philip BK, Pearman MH, Kovac AL, Chelly JE, Wetchler BV, McKenzie R, Monk TG, Dershwitz M, Mingus M, Sung YF, Hahne WF, Brown RA.
    Eur J Anaesthesiol; 2000 Jan; 17(1):23-32. PubMed ID: 10758440
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis.
    Zarate E, Watcha MF, White PF, Klein KW, Sa Rego M, Stewart DG.
    Anesth Analg; 2000 Jun; 90(6):1352-8. PubMed ID: 10825320
    [Abstract] [Full Text] [Related]

  • 12. Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting.
    Meyer TA, Roberson CR, Rajab MH, Davis J, McLeskey CH.
    Anesth Analg; 2005 Feb; 100(2):373-377. PubMed ID: 15673860
    [Abstract] [Full Text] [Related]

  • 13. Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.
    Lofters WS, Pater JL, Zee B, Dempsey E, Walde D, Moquin JP, Wilson K, Hoskins P, Guevin RM, Verma S, Navari R, Krook JE, Hainsworth J, Palmer M, Chin C.
    J Clin Oncol; 1997 Aug; 15(8):2966-73. PubMed ID: 9256141
    [Abstract] [Full Text] [Related]

  • 14. Dolasetron for the prevention of postoperative vomiting in children undergoing strabismus surgery.
    Wagner D, Pandit U, Voepel-Lewis T, Weber M.
    Paediatr Anaesth; 2003 Jul; 13(6):522-6. PubMed ID: 12846709
    [Abstract] [Full Text] [Related]

  • 15. Dolasetron versus ondansetron as single-agent prophylaxis for patients at increased risk for postoperative nausea and vomiting: a prospective, double-blind, randomized trial.
    Birmingham SD, Mecklenburg BW, Lujan E, Dacanay RG, Boyle PK, Green R.
    Mil Med; 2006 Sep; 171(9):913-6. PubMed ID: 17036618
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oral dolasetron mesylate for prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. The Oral Dolasetron PONV Prevention Study Group.
    Diemunsch P, Korttila K, Leeser J, Helmers JH, Wilkey B, Navé S, Radke AJ, Hahne WF, Brown RA.
    J Clin Anesth; 1998 Mar; 10(2):145-52. PubMed ID: 9524901
    [Abstract] [Full Text] [Related]

  • 19. [Prevention of post-operative nausea and vomiting. Randomised comparison of dolasetron versus dolasetron plus dexamethasone].
    Piper SN, Triem JG, Röhm KD, Kranke P, Maleck WH, Boldt J.
    Anaesthesist; 2003 Feb; 52(2):120-6. PubMed ID: 12624696
    [Abstract] [Full Text] [Related]

  • 20. Ondansetron versus dolasetron: a comparison study in the prevention of postoperative nausea and vomiting in patients undergoing gynecological procedures.
    Browning BA, Fort CA, Kemp KD, Shimata MF, Strube MD.
    AANA J; 2004 Apr; 72(2):129-32. PubMed ID: 15098526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.